Aetiological treatment with itraconazole or ketoconazole in individuals with Trypanosoma cruzi/HIV co-infection

References

• Akhavan, D. (2000). Analise de Custo-efetividade do Programa de Controle da Doença de Chagas no Brasil. Relatorio Final. Brasilia: Organização Pan-Americana da Saude.
   Google Scholar
• Anon. (2005). Consenso Brasileiro em doença de Chagas. Revista da Sociedade Brasileira de Medicina Tropical, 38 (Suppl. 3), 7-29.
   Google Scholar
• Anon. (2006a). Recomendavies para diagnóstico, tratamento e acompanhamento da co-infeccao Trypanosoma cruzi—virus da imunodeficiéncia humana. Revista da Sociedaele Brasileira de Medicina Tropical, 39, 392–415.
   PubMedGoogle Scholar
• Anon. (2006b). Certificação do Brasil como Area Interrompida de Transmissào da Doenfa de Chagas pelo T. infestans. Relatorio Técnico do Ministério da Sande, Brasil. Brasilia: Organizacao Pan-Americana da Saude.
   Google Scholar
• Apt, W., Aguilera, X., Arribada, A., Perez, C., Miranda, C., Sanchez, G., Zulantay, I., Cortés, P., Rodriguez, J. & Juri, D. (1998). Treatment of chronic Chagas' disease with itraconazole and allopurinol. American Journal of Tropical Medicine and Hygiene, 59,133–138.
   PubMed Web of Science ®Google Scholar
• Berens, R. L., Marr, J. J., Looker, D. L., Nelson, D. J. & LaFon, S. W. (1984). Efficacy of pyrazolopyrimi-dine ribonucleosides against Trypanosoma studies in vitro and in vivo with sensitive and resistant strains. Journal of Infectious Diseases, 150, 602–608.
   PubMed Web of Science ®Google Scholar
• Brener, Z., Cançado, J. R., Galvdo, L. M., da Luz, Z. M., Filardi, L. de S., Pereira, M. E., Santos, L. M. & Cançado, C. B. (1993). An experimental and clinical assay with ketoconazole in the treatment of Chagas' disease. Memórias do Institut° Oswaldo Cruz, 22, 149-153.
   Google Scholar
• Cahn, P., Belloso, W. H., Murilli, J. & Prada-Trujillo, G. (2000). AIDS in Latin America. Infectious Disease of Clinics of North America, 14, 1-5.
   PubMed Web of Science ®Google Scholar
• Castro, J. A., de Mecca, M. M. & Bartel, L. C. (2006). Toxic effects of drugs used to treat Chagas' disease (American trypanosomiasis). Human and Experimental Toxicology, 25, 471–479.
   PubMed Web of Science ®Google Scholar
• Corti, M. (2000). AIDS and Chagas'disease. AIDS Patient Care and STDs, 14, 581–588.
   PubMed Web of Science ®Google Scholar
• Del Castillo, M., Mendoza, G. & Oviedo, J. (1990). AIDS and Chagas' disease with central nervous system tumor-like lesion. American Journal of Medicine, 8, 693–694.
   Web of Science ®Google Scholar
• Filardis, L. S. & Brener, Z. (1987). Susceptibility and natural resistence of Trypanosoma cruzi strains to drugs used clinically in Chagas' disease. Transactions of the Royal Society of Tropical Medicine and Hygiene, 81, 755–759.
   PubMed Web of Science ®Google Scholar
• Goad, L. J., Berens, R. L., Marr, J. J., Beach, D. H. & Holz Jr, G. G. (1989). The activity of ketoconazole and other azoles against Trypanosoma cruzi: biochem-istry and chemotherapeutic action in vitro. Molecular and Biochemical Parasitology, 31, 179-190.
   Google Scholar
• Livramento, J. A., Machado, L. R. & Spina-Franca, A. (1989). Anormalidades do liquido cefalorraqueano em 170 casos de AIDS. Arquivos de Neuropsiquiatria, 47, 326-331.
   PubMedGoogle Scholar
• Moreira, A. A. B., de Souza, H. B. T. & Amato Neto, V. (1992). Avaliaçáo da atividade terapeutica do itraconazol nas infecvies cronicas, experimental e humana pelo Trypanosoma cruzi. Revista do Institut° de Medicina Tropical de Sao Paulo, 34, 177–180.
   PubMed Web of Science ®Google Scholar
• Oliveira Santos, E., dos Reis Canela, J., Gomes Monc“do, H. C. & Guedes Roque, M. J. (2002). Reactivation of Chagas' disease leading to the diagnosis of acquired immunodeficiency syndrome. Brazilian Journal of Infectious Diseases, 6, 317-321.
   Google Scholar
• Rassi, A. Jr, Rassi, A. & Little, W. C. (2000). Chagas' heart disease. Clinical Cardiology, 23, 883-889.
   PubMed Web of Science ®Google Scholar
• Sartori, A. M., Shikanai-Yasuda, M. A., Amato Neto, V. & Lopes, M. H. (1998). Follow-up of 18 patients with human immunodeficiency virus infection and chronic Chagas' disease with reactivation of Chagas' disease causing cardiac disease in three patients. Clinical of Infectious Diseases, 26, 177–179.
   PubMed Web of Science ®Google Scholar
• Sartori, A. M., Ibrahim, K. Y., Nunes, E. V. W., Braz, L. M., Oliveira Jr, O. C., Gakiya, E., Lopes, M.H. & Shikanai-Yasuda, M. A. (2007). Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS. Annals of Tropical Medicine and Parasitology, 101, 1-50.
   Google Scholar
• Solari, A., Saavedra, H., Sepulveda, C., Oddó, D., Acuria, G., Labarca, J., Murioz, S., Cuny, G., Brengues, C., Veas, F. & Bryan, R. T. (1993). Successful treatment of Trypanosoma cruzi encepha-litis in a patient with hemophilia and AIDS. Clinical Infectious Diseases, 16, 255–259.
   PubMed Web of Science ®Google Scholar
• Toledo, M. J., Bahia, M. T., Carneio, C. M., Martins-Filho, O. A., Tibayrenc, M., Barnabé, C., Tafuri, W. L. & de Lana, M. (2003). Chemotherapy with benznidazole and itraconazole for mice infected with different Trypanosoma cruzi clonal genotypes. Antimicrobial Agents and Chemotherapy, 47, 223–230.
   PubMed Web of Science ®Google Scholar
• Urbina, J. A. (1997). Lipid biosynthesis pathways as chemotherapeutic targets in kinetoplastid parasites. Parasitology, 114, 91–99.
   PubMed Web of Science ®Google Scholar
• Urbina, J. A. (1999). Chemotherapy of Chagas' disease: the how and the why. Journal of Molecular Medicine, 77, 332–338.
   PubMed Web of Science ®Google Scholar
• Urbina, J. A., Lazardi, K., Marchan, E., Visbal, G., Aguirre, T., Piras, M. M., Piras, R., Maldonado, R. A., Payares, G. & de Souza, W. (1993). Mevinolin (Lovastatin) potentiates the antiproliferative effects of ketoconazole and terbinafine against Trypanosoma (Schizottypanum) cruzi: in vitro and in vivo studies. Antimicrobial Agents and Chemotherapy, 37, 580–591.
   PubMed Web of Science ®Google Scholar
• Urbina, J. A., Payares, G., Molina, J., Sanoja, C., Liendo, A., Lazardi, K., Piras, M. M., Piras, R., Perez, N., Wincker, P. & Ryley, J. F. (1996). Cure of short and long-term experimental Chagas' disease using D0870. Science, 273, 969–970.
   PubMed Web of Science ®Google Scholar
• Urbina, J. A., Payares, G., Contreras, L. M., Liendo, A., Sanoja, C., Molina, J., Piras, M., Piras, R., Perez, N., Wincker, P. & Loebenberg, D. (1998). Antiproliferative effects and mechanism of action of SCH 56592 against Trypanosoma (Schizottypanum) cruzi: in vitro and in vivo studies. Antimicrobial Agents and Chemotherapy, 42, 1771–1777.
   PubMed Web of Science ®Google Scholar
• Yoo, T. W., Mlikotic, A., Cornford, M. E. & Beck, C. K. (2004). Concurrent cerebral American trypano-somiasis and toxoplasmosis in AIDS. Clinical Infectious Diseases, 39, e30–e34.
   PubMed Web of Science ®Google Scholar